Disease Control and Prevention, that trains pharmacists to provide immunizations, 8 and the National Community Pharmacists Association offers a certificate program that provides information on setting up a community-based immunization program. 9 In summer 1998 researchers from West Virginia University (WVU) conducted a national survey to assess pharmacists' participation in immunization activities (counseling, partnership with nurses, administering, and promotion), willingness to provide immunization services, and perceptions of obstacles to providing immunization services. 6 More than 3 years elapsed between that survey and the survey discussed in the present article. During that time, APhA conducted most of the immunization-related training programs being offered, 8 and several chain pharmacy organizations implemented immunization services. 10, 11 These developments suggested that, 3 years after the first survey, a follow-up national survey to assess changes in pharmacist involvement in immunizations and their perceived impact would be timely and important.
Pharmacists' feedback on their experiences with immunization services is desirable for other reasons, too. The number of pharmacy-based immunizations has increased dramatically in several states, including Georgia, Michigan, Mississippi, and Washington. 12 Grabenstein et al. 13 showed that about 1,500 pharmacists administered more than 100,000 vaccine doses in 1997, and these numbers increased to some 2,500 pharmacists administering more than 300,000 vaccine doses in 1999. Since 1999 chains such as Giant Food in Maryland have been running vaccination campaigns in which pharmacists administer flu and pneumococcal vaccines. 11 Influenza immunizations were offered in 19% of grocery stores in 1997. 13 While influenza vaccines account for the majority of pharmacist-administered immunizations, pharmacists are also administering vaccines for hepatitis A and B, Lyme disease, tetanus, and chicken pox. 12 Given the growing public acceptance of pharmacy-based immunizations, the valuable experience that pharmacists are gaining can be used to identify and communicate what makes immunization programs successful. From a public health perspective, the impact of pharmacist-administered immunizations needs to be assessed in terms of their current and potential contributions to the realization of the Healthy People 2010 goals for immunizations. [14] [15] [16] 
Objectives
The objectives of the study were to survey a random national sample of pharmacists to (1) determine their current involvement in immunization services; (2) obtain information about their willingness to provide immunization services, perceived obstacles to providing immunization services, and perception of consumer interest in pharmacy-provided immunization services in their communities; and (3) describe the characteristics of pharmacistadministered immunization services.
Methods
We developed a mailed questionnaire titled "Pharmacy and Immunization Services: Pharmacists' Participation and Impact," based on the first national pharmacists' immunization survey instrument. 6 We reviewed the literature to identify additional issues of relevance to study objectives 2 and 3. Also, we sought and incorporated input from key executives of APhA, the sponsor of the study, and the chair of APhA's Immunization Advisory Committee.
The first section of the questionnaire gathered information about pharmacists' current involvement in immunization services, their willingness to provide immunization services, whether their state allowed them to administer immunizations, and whether they had ever attended a training program pertaining to immunizations. Pharmacists were then asked about immunization-related activities, including counseling, hosting nurses who administer immunizations, administering immunizations personally, and promoting immunizations. Their willingness to provide immunization services, regardless of whether they currently did so, was measured using a 7-point Likert scale, with 1 = least willing and 7 = most willing.
In the second section, pharmacists, regardless of their current involvement in immunization services, were asked to rate on a 7-point Likert scale (1 = no problem, 7 = major problem) the extent to which each of 14 factors was problematic in terms of provision of immunization services. The factors listed were those commonly identified in the literature and through the previous survey as obstacles to pharmaceutical care, such as lack of reimbursement; availability of time, space, or staff; physician support; state laws; and legal liability. 6, 17, 18 In the third section, pharmacists rated on a 7-point Likert scale (1 = no problem, 7 = major problem) the extent to which selected factors were problematic in terms of patients' use of pharmacybased immunization services. Factors included insurance coverage, distance traveled to pharmacy, waiting time, and cost, safety, and effectiveness of vaccines.
The fourth section collected information about who administered immunizations in the pharmacy, number and doses of immunizations administered in the previous 1-year period, personnel time spent on immunizations, adverse reactions noted, compensation received, liability insurance purchased, sources of vaccine supply, and perceived impact of the service on practice. If pharmacists were administering immunizations in the pharmacy, information was gathered about total number of childhood and adult doses given in 2000, times when pharmacist administered immunizations, number of support staff, and start-up and maintenance costs.
The fifth section collected respondents' demographic information-age, sex, years in practice, and education. Practice-related information, including job title, practice site, staff numbers, prescription volume, hours per week pharmacy is open, and availability of a designated patient counseling and immunization area, was also collected.
The sampling frame for the national study was obtained from SK&A Inc., a private mailing list firm. In fall 2001 a total of 6,000 randomly selected pharmacists (5,000 in community, 500 in hospital, and 500 in long-term care pharmacies) were sent a questionnaire accompanied by a cover letter in an APhA envelope. The sample size of 6,000 was selected per APhA's request. Cover letters for the survey were signed by APhA Executive Vice President John A. Gans, PharmD, and by John D. Grabenstein, PhD, chair of the APhA Immunization Advisory Committee. The questionnaire and the cover letters were approved by WVU's Institutional Review Board.
The cover letter explained that the study was a collaborative effort between APhA and the WVU School of Pharmacy, noted the importance of determining pharmacist involvement in immunizations, and appealed to pharmacists to complete the survey. The letter explained that participation was voluntary, and confidentiality was assured. The survey was followed 1 week later by a postcard reminder. To increase the response rate, nonrespondents were sent two other questionnaires at intervals of 3 weeks. Finally, about 12 weeks after the first mailing, we mailed a 1-page nonresponse questionnaire to 350 randomly selected nonresponding pharmacists to assess nonresponse bias. Through the nonresponse survey, we were able to obtain critical demographic and immunization-related information and elicit reasons for nonparticipation.
Data Analysis
Frequency distributions were developed for respondents' practice characteristics. c 2 analyses were used to assess differences in the provision of immunization services by practice characteristic. Multivariate analysis of variance (MANOVA) was used to assess whether respondents, when categorized by practice site and job title, differed with regard to their willingness to provide immunization services and perceived obstacles to provision of immunization services. The Dunnett T3 post hoc test was used to identify significant differences within a main effect if the multivariate test (F ratio) for main effect was significant. Exploratory factor analysis was performed to identify the underlying dimensions of obstacles that pharmacists perceive to providing immunization services. All statistical analyses were performed using SPSS for Windows, Version 10.1. An a priori a£ 0.05 was set for all statistical tests.
Results

Response Rate
Of 6,000 surveys mailed, 42 (0.007%) were returned due to incorrect addresses. Thus, 5,958 pharmacists were presumably reached by the mailings. A total of 1,266 usable surveys were returned after 4 mailings, for a response rate of 21.2%.
N onrespondents' Characteristics
Of the 350 nonrespondent surveys mailed, 74 (21.1%) were returned. Pharmacists gave the following reasons for nonparticipation: lack of time (28.8%); misplaced the survey (10.2%); topic irrelevant (6.8%); insufficient incentive to participate (6.8%); did not receive survey (8.5%); survey was cumbersome (5.1%); do not normally respond to surveys (6.8%); no interest in immunizations or against pharmacists administering immunizations (6.8%); forgot (3.4%); lack of knowledge about topic (3.4%); and other reasons (13.6%). No significant differences were noted between respondents and nonrespondents in terms of age, years of pharmacy practice, or practice characteristics such as number of pharmacists at the site and average prescription volume. Nor were any significant differences found between respondents and nonrespondents in terms of whether they currently provided immunization services. Although both groups were equally willing to counsel on and administer childhood and adult immunizations, respondents were more willing to promote childhood and adult immunizations.
Respondents' Characteristics
Of the 1,265 respondents, 597 (47.2%) were women and 668 (52.8%) were men. Mean age in years ± standard deviation (SD) was 42.5 ± 11.9, and mean number of years in pharmacy practice experience was 17.4 ± 12.3.
Mean age in years and mean number of years in pharmacy practice differed across practice sites: Those working in independent settings were slightly older (48.2 ± 12.2) and had more pharmacy practice experience (23.4 ± 12.6) than those in chain (39.2 ± 11.1; 14.1 ± 11.4), institution (43.6 ± 10.9; 18.4 ± 11.3), or other settings (42.1 ± 9.7; 16.0 ± 9.9). The nine practice-type sites were collapsed into four categories in all subsequent analysis involving practice site: chain pharmacy (chain, mass merchandiser, grocery); independent pharmacy (independent pharmacy and primary care clinic); institutional pharmacy (health maintenance organization, hospital outpatient clinic, and hospital inpatient); and other (government facility, long-term care, home health care, and other site).
Of the respondents working in independent settings, 49 (15.0%) reported having a designated immunization area, while only 20 (3.2%) and 4 (3.6%) reported having such an area in chain and institutional settings, respectively. Four hundred thirty-two (68.2%) respondents from chain pharmacies and 196 (58.9%) from independent pharmacy settings reported having a patient counseling area. Chain pharmacists reported a mean of 2.5 ± 3.2 pharmacists and 3.3 ± 5.2 technicians, whereas independent pharmacists reported 2.2 ± 1.9 pharmacists and 2.6 ± 2.6 technicians at their primary practice site. Chain pharmacists reported a greater average prescription volume (242 ± 229 versus 195 ± 146.8) and longer hours (78 hours ± 22.3 versus 57 hours ± 14.9) than did independent pharmacists. Pharmacists from other settings reported having the highest number of nonpharmacy staff (5.7 ± 13.1) and highest daily prescription volume (853.3 ± 1,021.4 prescriptions/day).
Nine hundred twenty-five (78.0%) respondents reported having a bachelor of science (BS) degree in pharmacy, 130 (11.0%) reported having a doctor of pharmacy (entry level) degree, 84 (7.1%) reported having a post-BS doctor of pharmacy degree, and 31 (2.6%) reported having master degrees. One hundred seventyseven (14%) respondents were owner/partners, 281 (22.2%) were chief/head pharmacists, and 564 (44.7%) were staff pharmacists. Five hundred forty-five (45.5%) respondents practiced in chain pharmacy, 322 (26.9%) practiced in independent pharmacy, and 105 (8.8%) practiced in mass merchandiser/grocery store settings.
Of those who indicated their state allowed pharmacists to administer immunizations, 55.3% correctly answered the question, 15.9% were incorrect in their responses, and 28.8% did not know. Figure 1 shows respondents' current involvement in immunizations. Table 1 breaks down pharmacists' involvement by job title and practice site. Owner/partner/store manager pharmacists were more likely to be involved in administering adult immunizations and counseling about childhood and adult immunizations than were chief or staff pharmacists. Staff pharmacists were more likely to report nurse-administered adult and childhood immunizations than were owner/partner/store manager and chief pharmacists. Chain pharmacists were more likely to report counseling about adult and childhood immunizations than were respondents from any other site. Additionally, chain pharmacists were more likely to report nurse-administered adult immunizations and immunization promotion than were respondents from any other site. Independent pharmacists were more likely to report administering adult immunizations than were those from any other site.
O bjective 1: Current Involvem ent in Im m unization Services
O bjective 2: W illingness to Provide and Perceived O bstacles to Providing Im m unization S ervices W illingness to Provide Im m unization Services
Pharmacists were asked about their willingness to provide specific immunization services, such as counseling, administering, or promoting childhood and adult immunizations.
Overall, on a scale of 1 to 7, where 1 = least willing and 7 = most willing, respondents were very willing to counsel and promote (mean > 5.0) childhood and adult immunizations. Among those who were willing to administer vaccines, willingness was greater for adult (4.4 + 2.6) than childhood (3.9 + 2.7) immunizations (see Figure 2) .
MANOVA was used to test whether differences in willingness to get involved in various types of immunization services existed by practice site and job title. No statistically significant F values were found for the main effect of job title (F = 1.091; P = .363) and the interaction between practice site and job title (F = 0.829; P = .754). However, there was a statistically significant main effect for practice site (Wilks l = 0.931; F = 4.008; P = .001). Further investigation revealed that respondents in chain settings were more willing to counsel on childhood immunizations than were those in independent settings. Also, respondents from other settings were more willing to counsel on and promote adult immunizations than were those in independent settings (see Tables 2 and 3 ). Figure 3 lists the factors that pharmacists perceived as problematic regarding the provision of immunization services. Availability of time, concern about legal liability, level of reimbursement, staff support, availability of area within the pharmacy, and pharmacist's a Respondents checked all applicable responses; therefore, percentages total more than 100% .
Perception of O bstacles to the Provision of Im m unization Services
% respondents level of training were some of the factors perceived as most problematic. These factors had a mean value between 4.6 and 5.5 on a 1 (no problem) to 7 (major problem) scale, indicating that they were of moderate concern.
We performed exploratory factor analysis (principal components with varimax rotation) to identify underlying dimensions among the perceived obstacles (see Table 4 ). Four factors emerged with eigen values greater than 1: legal liability and reimbursement, immunization ability and legislative requirements, external support, and internal support and infrastructure. The reliability of the factors was assessed using the Cronbach coefficient a, a measure of internal consistency.
MANOVA was used to test whether differences in the four underlying dimensions of perceived obstacles existed by practice site and job title. No statistically significant F values were seen for the main effect of job title (F = 1.011; P = .426) and the interaction between practice site and job title (F = 0.969; P = .235). However, there was a statistically significant main effect for practice site (Wilks l= 0.897; F = 8.529; P = .001). Further investigation revealed that respondents in chain settings were more con- cerned about immunization ability and legislative requirements than respondents in independent settings. Respondents from chain settings were also more concerned about internal support and infrastructure than were pharmacists in independent or other settings. Pharmacists in institution settings were more concerned about internal support and infrastructure than were respondents in independent settings (see Tables 5 and 6 ).
Consum er Interest in Pharm acy-Based Imm unization
Services Figure 4 shows the extent to which pharmacists perceived selected factors as problematic in terms of patients' use of pharmacy-based immunization services. Availability of insurance coverage for immunizations, out-of-pocket costs for immunizations, and average waiting time for immunizations were the top three factors identified. These factors had mean values between 3.7 and 5.0 on a 1 (no problem) to 7 (major problem) scale, indicating that they were not very significant concerns.
O bjective 3: Characteristics of Pharm acistAdm inistered Im m unization Services Im m unizers
Of those who provided immunizations in their pharmacies, 78 (19.6%) reported that pharmacists administered immunizations, 308 (77.6%) reported that another health care provider did so, and 11 (2.8%) reported that both administered immunizations.
Types and Doses of Vaccines Administered by Pharm acists
Pharmacists in chain and independent pharmacies administered most available vaccines. Influenza and pneumococcal vaccines were most frequently provided in all settings (see Table 7 ). The mean doses of influenza and pneumococcal vaccines administered by chain pharmacists in 2001 were 374.2 ± 437.2 and 46.1 ± 49.4, respectively. The mean doses of influenza and pneumonia vaccines administered by independent pharmacists in 2001 were 720.3 ± 1,209.7 and 58.2 ± 76.6, respectively (see Table 8 ).
Support Staff
Chain pharmacists reported mean numbers of 2.1 ± 0.9 pharmacists, 2.4 ± 1.2 technicians, and 1.1 ± 0.6 nonpharmacy staff present when pharmacists administered immunizations. Independent pharmacists reported mean numbers of 1.7 ± 0.9 pharmacists, 2.4 ± 2.3 technicians, and 1.6 ± 0.8 nonpharmacy staff present.
Adverse Reactions O bserved
Four (18.0%) pharmacists in other settings, 34 (15.1%) in chain settings, and 10 (14.5%) pharmacists in independent settings reported observing adverse reactions following immunizations in their pharmacies. The most common local reactions reported were redness, swelling, and/or rash. Systemic reactions reported were fever, muscle aches, headaches, nausea/vomiting, and/or fainting. No anaphylactic reactions were reported.
Sources of Vaccines and Com pensation
Wholesalers and manufacturers were the primary sources of vaccines in all practice settings. The primary sources of compensation for immunization services were cash in chain and independent settings and Medicare in institutional settings. immunization services had the greatest impact on their professional image, followed by professional satisfaction, market share, and financial impact (see Figure 5 ).
Insurance Coverage for Imm unization Services
A vast majority of respondents (> 94%) reported that their existing liability insurance policy provided sufficient coverage when immunization services were first offered. When additional liability insurance was purchased, chain and independent pharmacists paid an additional average annual premium of about $12 and $11, respectively.
Start-up Cost and M ean Cost per M onth to Maintain Pharm acist-Adm inistered Imm unization Services
Chain pharmacists reported a mean total cost of $378.00 ± $554.70 to initiate a pharmacist-administered immunization service and a per month cost of $1,268.00 ± $2,457.30 to maintain it. Independent pharmacists reported a mean total cost of $739.00 ± $849.90 to initiate a pharmacist-administered immunization service and a monthly mean cost of $208.00 ± 292.50 to maintain it.
Discussion
The 2001 national survey was undertaken as a follow-up to a survey conducted in late summer 1998. 6 The mailings coincided with the aftermath of the September 11, 2001 , terrorist attack in New York City and the anthrax postal service scares. An unusually high number of pharmacists called to tell us they had not received an earlier mailing, and, in general, survey responses were considerably delayed throughout the data collection period. We suspect that the low response rate was to some extent due to the prevailing circumstances.
In this survey, we assessed the current immunization-related practice behavior of pharmacists, the obstacles they perceived to providing these services, and information about pharmacistadministered immunization services. Our results suggest that pharmacists' roles in providing immunization services have changed considerably. Having become involved initially as educators on and facilitators of immunizations, pharmacists are increasingly taking on the role of immunizers, moving into an area that has been the traditional domain of nurses, nurse practitioners, and physicians. 11 Compared with the findings of the 1998 national survey, our results survey indicate that pharmacists appeared to be more involved in all aspects of immunization-related services in 2001. Immunization activities that reportedly increased during the period between the surveys include counseling about adult immunizations (from 11.9% to 14.7%), nurse-administered childhood immunizations (6.3% to 7.8%), nurse-administered adult immunizations (16.2% to 30.2%), pharmacist-administered childhood immunizations (0.9% to 1.3%), pharmacist-administered adult immunizations (2.2% to 6.8%), and immunization promotion (18.9% to 27.3%). Only counseling on childhood immunizations appears to have decreased slightly, from 13.4% to 8.9%.
Nurse-administered adult and childhood immunizations increased during this period. Pharmacies have been hosting nurses to provide immunizations for a long time. 13 Many chain, food, and mass merchandising store pharmacies employ nurses during flu season to immunize adults. Recently, Walgreens implemented a childhood immunization program called Shots for Tots in the Chicago area, in which nurses administer childhood immunizations in the pharmacy. 11 In 1997 nurses administered more than 5 million doses of influenza vaccine alone in more than 15,000 pharmacies nationwide. 13 Collaboration with nurses is important for pharmacists, whose immunization-related activities are often limited by state legislation, time constraints, personal preference, lack of experience with injections, and other factors.
As our results indicate, pharmacists tend to be more involved in adult immunizations than childhood immunizations. This could be due to greater patient acceptance of nontraditional immunizers for adults. 3 Childhood vaccination schedules are complex and need careful monitoring, and pediatricians still deliver the largest share of childhood vaccinations as part of well baby checkups. 11, 19 Therefore, pharmacists have been slow to get involved in this service and have generally limited their role to providing information. 11 Willingness to provide immunization services also increased during the 1998-2001 period. Willingness was found to be significantly related to practice site. Willingness was not found to be associated with age, years of practice, or job title; these results indicate a similar level of interest in immunization across pharmacists. Compared with pharmacists in independent pharmacies, chain pharmacists were more willing to counsel on childhood immunizations, and pharmacists in other types of pharmacies were more willing to counsel on and promote adult immunizations. In contrast to independent pharmacies, chain pharmacies have traditionally focused on discount pricing and large-scale merchandising to attract customers. As stated earlier, many have now started offering pharmacist-administered immunizations. These pharmacies also organize flu vaccination campaigns and host nurses to provide adult and childhood immunizations. 10, 11 Pharmacists in independent settings, on the other hand, appear to be more entrepreneurial than pharmacists in other practice settings. 6 To compete better with chain pharmacies and discount pharmacies, independent pharmacies are known to offer new services that emphasize patient care. Thus, with both independent and chain pharmacies offering such services, pharmacy-based immunizations appear to be gaining ground. Perceived obstacles to the provision and patients' use of immunization services mirrored those noted in the earlier study, 6 although the ostacles were perceived as slightly less problematic. Pharmacists reported lack of time, concern for legal liability, and lack of reimbursement as the top three obstacles. Insurance coverage and out-of-pocket costs for immunizations were perceived as being most problematic for patients in using pharmacy-based immunization services. Lack of time for immunization and other patient care services is always a concern when pharmacies try to increase prescription volume to compensate for decreasing gross margins on prescriptions and decreasing pharmacist numbers in favor of more technicians. 6 Our results suggest that in most instances, existing liability insurance is sufficient to provide coverage for immunization services, and when additional liability insurance is necessary, the premium is not very high. Concern about legal liability stems from the association of several immunizations with adverse reactions. 11 Pharmacists need to be more informed about the National Childhood Vaccine Injury Act of 1986, which specifically addresses the concerns of vaccine manufacturers and providers. 6 The U.S. Court of Federal Claims in Washington, D.C., serves as the primary arbitrator and payer of all vaccine-injury claims in conjunction with the U.S. Department of Health and Human Services and the U.S. Department of Justice. 6 Also, additional liability coverage is available from insurance companies for a nominal increase in premiums.
Reimbursement for immunization services has been improving. There is evidence that Medicare, some managed care organizations, and even patients are paying pharmacists for their time and expertise. 10, 11, 20 In the state of Washington, pharmacists have received provider identification numbers-used for billing for the administration of influenza and pneumococcal vaccines and other vaccine products-from the Centers for Medicare & Medicaid Services (formerly the Health Care Financing Administration). 10 During flu season, chain pharmacies employ nurses to administer adult immunizations. This reflects their management's concerns about the immunization ability of pharmacists, time and space available for immunizations, and staff and management support. Also, chain pharmacies employ higher numbers of staff and are open for longer periods of time, factors that could explain their higher maintenance costs, compared with independent pharmacies, for pharmacist-administered immunization services.
Also, start-up costs and average monthly cost to maintain pharmacist-administered immunization services appear to be manageable. These findings suggest that financial obstacles alone need not deter pharmacists from providing such services.
Our results indicate that pharmacists are involved in immunization services in three different ways: as advocates, partners, and providers. Additionally, pharmacists are considered the most accessible health care professionals. 6 Owing to this unique position, pharmacists have a tremendous opportunity to contribute to the achievement of Healthy People 2010 goals for immunization.
Limitations
This study has all of the limitations associated with cross-sectional survey design methodology. Caution should, therefore, be exercised when extrapolating the findings to the entire pharmacist population, for this and the following reasons. The low response rate, which we believe was partly due to the national terrorism crisis at the time of the survey, is a concern. The data were not adjusted for differences between sample and population characteristics; therefore, variation in regional attitudinal and practice characteristics may also explain some of the differences noted above. In many instances, because of the low response rate, there is a possibility of underreporting of results (e.g., number of doses of vaccine administered by pharmacists [ Table 8 ]). These variations become larger when smaller subgroups are analyzed. 
Conclusion
Pharmacist involvement in immunizations has increased since the baseline survey in 1998. Although pharmacist-administered childhood immunizations increased slightly, pharmacist-administered adult immunizations rose from 2.2% to 6.8%. Overall, willingness to provide immunization services has increased, and perceptions of obstacles to the provision of immunization services have diminished. A variety of childhood and adult vaccines are administered in pharmacies by nurses and/or pharmacists, with influenza vaccines accounting for the majority. Financial considerations for starting and maintaining pharmacy-based immunizations appear to be minimal. 
